Clinicians with an interest in thrombophilia: Attend our next NBCA Journal Club session!
The NBCA Journal Club highlights groundbreaking research in thrombosis and thrombophilia and features a manuscript author as part of the discussion.
Our next session convenes June 18, 2024 from 2-3 p.m. ET to discuss, "Antithrombin Therapy: Current State and Future Outlook," published in Clinical and Applied Thrombosis/Hemostasis in 2023.
The paper’s author, George M. Rodgers, III, MD, PhD, Professor of Medicine in the Division of Hematology and Hematologic Malignancies at the University of Utah School of Medicine, will join us to discuss his research.
The session’s learning objectives:
- Understand the genetic and acquired factors contributing to antithrombin (AT) deficiency and its implications.
- Explore current treatment strategies for managing AT deficiency.
- Identify specific patient populations and use cases where AT therapy may be considered and evaluate its potential benefits.
- Investigate advancements and future directions in research, diagnosis, and treatment approaches for AT deficiency to enhance clinical outcomes and patient care.
Register: bit.ly/NBCAJournalClub2024
#stoptheclot #nbcajounalclub #bloodclots #thrombophilia #thrombosis #antithrombintherapy #antithrombindeficiency #bloodcloteducation #continuingeducation